An Ethereum MEV bot named Yoink intercepted a $7.8 million exploit attempt on a Safe wallet involving 2,900 rsETH by paying nearly 19 ETH to secure the first transaction position in the same block. The exploit was due to weak authorization checks in an executor contract linked to a Safe module, allowing unauthorized calls through a trusted route. Yoink's transaction succeeded while the original exploit reverted, highlighting the bot's role in capturing maximal extractable value (MEV) by prioritizing transaction order. No recovery or legal actions have been reported yet, and this incident adds to significant DeFi losses in 2026 caused by compromised credentials and smart contract flaws.
The Ethereum MEV bot incident provides context for cryptocurrency market activity. For readers following crypto, here is Pluang's market snapshot as of Sep 15, 2026 22:41 WIB: out of 50 major cryptocurrencies, 10 rose and 39 fell. Notably, SXP dropped sharply by 46.27% to Rp37 with a typical hold time of 94 days, FIL declined 12.57% to Rp15,269 with 67% sell orders and a 99-day hold, while BAL rose 11.14% to Rp16,297 with an 85-day hold time.
Waystar Holding Corp, a healthcare software company valued at around $5.1 billion, saw its stock rise 8.6% to $27.05 following reports that it is evaluating strategic options, including a potential sale. Barclays set a new price target of $30, sugges...
MasterCraft Boat Holdings reported fiscal Q4 2026 adjusted earnings of $0.67 per share and revenue of $129.94 million, surpassing estimates. Revenue growth was driven by its Performance and Wake business and the Marine Products acquisition, which add...
Redwood Trust's CFO, Carillo Brooke, increased her stake by purchasing 26,065 shares, showing confidence despite a major shareholder urging the board to consider selling the company. The stock trades at a 33% discount to its GAAP book value due to ri...
BioMarin Pharmaceutical received a price target upgrade to $97 from BMO Capital, reflecting about 50% upside from current levels. This follows positive Phase 3 trial results for VOXZOGO®, a treatment for hypochondroplasia, showing significant growth ...
Comcast announced a strategic restructuring to separate its connectivity and technology division from its media operations, including NBCUniversal and Sky. UBS raised Comcast's price target to $27, suggesting a 10% upside from current prices. The com...
